Manjunath Lamani - Northeastern University

基本信息

浏览量：14

职业迁徙

个人简介

Manjunath Lamani currently works at the Center for Drug Discovery, Northeastern University. Manjunath does research in Medicinal Chemistry, Green Chemistry and Organometallic Chemistry. Their most recent publication is 'Total Synthesis of Thailanstatin A.'

研究兴趣

论文共 29 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase Inhibitors

Corinne N Foley, Shiwei Qu, Srinivas Reddy Paladugu,Manjunath Lamani, Rebecca Grange,Ehesan U Sharif,Joice Thomas, Pradeep Nareddy, Guiling Zhao, Yu Chen, Xiaoning Zhao,David Green, Hsin-Ting Huang,Lixia Jin, Susan L Paprcka, Ester Fernandez-Salas,Jay P Powers, Manmohan R Leleti, Dillon H Miles

Journal of medicinal chemistryno. 11 (2025): 10677-10703

引用0浏览0WOS引用

Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer Therapy

Dillon H Miles,Manjunath Lamani, Srinivas Reddy Paladugu, Shiwei Qu, Corinne N Foley,Ehesan U Sharif,Joice Thomas, Pradeep Nareddy,Joel W Beatty, Balint Gal, Guiling Zhao, Rebecca Grange, Stefan G Shaqfeh,Ada Chen,Hema Singh, Yue Tong Lee, Xiaoning Zhao,David Green, Hsin-Ting Huang,Elaine Ginn,Lixia Jin, Susan L Paprcka, Ester Fernández-Salas, Lian Zhou, Jordon Johnson, Lilian Adeojo,Jay P Powers, Manmohan R Leleti

Journal of medicinal chemistryno. 11 (2025): 10663-10676

引用0浏览0WOS引用

AB801 is a Highly Potent and Selective AXL Kinase Inhibitor That Demonstrates Significant Anti-Tumor Activity

Susan Lee Paprcka, Armon Goshayeshi,Suan Liu,Ruben Flores,Lauren Rocha,Jhansi L. Leslie,Dillon H. Miles,Corinne N. Foley,Shiwei Qu,Manjunath Lamani,Srinivas Paladugu, Hsin-Ting Huang, Nidhi Tribewal,Ada Chen,Joseph Kulusich,Stefan Garrido-Shaqfeh, Patricia Fabila, Salema Jafri, Anuja Devarajan,Ester Fernandez-Salas

Cancer Research (2023)

引用0浏览0引用

Design and Synthesis of Highly Potent and Specific ABHD6 Inhibitors

Michael S. Malamas,Manjunath Lamani,Shrouq Farah,Khadijah A. Mohammad,Christina Yume Miyabe,Girija Rajarshi,Simiao Wu,Nikolai Zvonok,Honrao Chandrashekhar,JodiAnne Wood,Alexandros Makriyannis

CHEMMEDCHEM（2023）

引用6浏览0WOS引用

AB801 is a Potent and Selective AXL Inhibitor That Demonstrates Significant Anti-Tumor Activity in Combination with Standard of Care Therapeutics

S. Paprcka,S. Sridhar, A. Goshayeshi, E. Park, S. Liu, R. Flores, L. Rocha,D. Miles,M. Lamani,S. Cho,N. Wang, Y. Guan, S. Chandrasekar,R. Kushwaha, S. Jafri, A. Kaplan,E. Stagnaro,L. Seitz, J. Kline, E. Fernandez-Salas

European Journal of Cancer（2022）

引用1浏览0引用

Discovery and Characterization of Potent and Selective AXL Receptor Tyrosine Kinase Inhibitor AB801

D. Miles, S. Paprcka,C. Foley, S. Qu,M. Lamani, S. Paladugu, H. T. Huang,N. Tibrewal,A. Chen, J. Kulusich, S. Garrido-Shaqfeh, P. Fabila,S. Sridhar, S. Liu, D. Swinarski,X. Zhao, E. Fernandez-Salas, D. Green,L. Jin,M. Leleti

European Journal of Cancer（2022）

引用0浏览0引用

WITHDRAWN: Design and Synthesis of Highly Potent Dual ABHD6/MGL Inhibitors